XSurgical

XSurgical

Growth Stage

We move the technology, not the patients.

We move the technology, not the patients.

Overview

Raised to Date: Raised: $44,616

Total Commitments ($USD)

Platform

StartEngine

Start Date

12/16/2021

Close Date

04/20/2022

Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment

$100

Security Type

Equity - Preferred

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$4.00

Pre-Money Valuation

$25,000,000

Rolling Commitments ($USD)

Status
Funded
Reporting Date

04/29/2022

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$360

# of Investors

112

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Logos provided by Clearbit
Year Founded

2018

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Low

Capital Intensity

High

Location

Cambridge, Massachusetts

Business Type

Growth

Company Website

XSurgical, with a pre-money valuation of $25 million, is raising funds on Startengine. The company plans to take to market what Management believes to be the first surgical robot capable of both operating in hospitals and portable in the open field, integrating minimally invasive, open surgery and orthopedic procedures. This technology will bring the expertise and skills of a top surgeon to perform complex, surgical procedures in remote locations. XSurgical was founded by Gianluca De Novi, Michele Marzola, and Debora Botturi in 2018. The current crowdfunding round has a minimum goal of $10,000 and a maximum goal of $1,070,000.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-134,787

$-210,843

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$2,467

$70,170

Accounts Receivable

$0

$0

Total Assets

$132,467

$210,170

Short-Term Debt

$39,412

$0

Long-Term Debt

$323,859

$308,438

Total Liabilities

$363,271

$308,438
Financials as of: 12/16/2021
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
XSurgical 10/12/2023 Netcapital $10,222,814 $15,972 Equity - Common Funded RegCF
XSurgical 04/19/2022 StartEngine $25,000,000 $44,616 Equity - Preferred Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
XSurgical on Startengine 2021
Platform: StartEngine
Security Type: Equity - Preferred
Valuation: $25,000,000
Price per Share: $4.00

Follow company

Follow XSurgical on Startengine 2021
View on StartEngine (Closed)
Deal Analytics
Company Ratings
Deal Considerations

Buy XSurgical's Deal Report

Warning: according to the close date for this deal, XSurgical may no longer be accepting investments.

XSurgical Deal Report

Get KingsCrowd’s comprehensive report on XSurgical including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether XSurgical is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the XSurgical deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge